Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Ann Med Res. 2007; 14(4): 237-240


The Effects of Beta-Carotene and Folic Acid on Vincristine-Induced Apoptosis

 

Erkan Yurtcu*, Özge Özalp Yüreğir**, Feride İffet Şahin**

.




Abstract


 

 

Background: A chemotherapeutic agent, vincristine, inhibits spindle fiber formation in both the neoplastic and normal cells. Reversal of apoptotic effects may be exerted by folic acid and beta-carotene addition in vitro. In this study, we aimed to investigate the effects of folic acid and beta-carotene added alone or together on vincristine induced apoptosis in human multiple myeloma cell line ARH77 and human chronic myeloid leukemia cell line K562 cultures.

Materials and Methods: Apoptosis was induced by 10-5M vincristine added to the cultures for 24, 48 and 72 hours. Folic acid and beta-carotene were added alone or together in 10-3 M and 10-7M respectively. Cell viability of every culture was determined after which at least 500 cells were analyzed for apoptotic features. Statistical comparisons of ratios were made with two proportion z test.

Results: In ARH77 cells, no significant decrease in apoptotic cell ratios were determined after folic acid and beta-carotene addition alone or together (p >0.05). Whereas, in K562 cells, after incubation with vincristine for 24 hours, apoptotic cell ratios were significantly reduced by folic acid and beta-carotene treatment one at a time or together (p






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.